<DOC>
	<DOCNO>NCT01085734</DOCNO>
	<brief_summary>Comparative study see treat Osurdex addition Avastin patient retinal vein occlusion help increase visual acuity outcome</brief_summary>
	<brief_title>Single Site , Masked , Randomized , Controlled Study Assess Efficacy Osurdex Adjunct Avastin Compared With Avastin Alone Treatment Patients With Macular Edema Due Central Branch Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>male female age 18 year old Branch retinal vein occlusion central retinal vein occlusion less one year duration Best correct visual acuity great 24 less 80 Presence macular edema define OCT central subfield thickness &gt; 250 intravitreal antiVEGF treatment study eye within six week baseline intravitreal steroid treatment study eye within eight week baseline visit PRP study eye within 4 month baseline visit Active iris neovascularization study eye Uncontrolled systemic disease Known history IOP elevation response corticosteroid treatment control 2 glaucoma medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>